The Independent (UK) today reports on the story that SPGB previously reported upon in June of how the pharmaceutical industry preys on the poor to trial new drugs. Clinical trials for new pharmaceutical drugs are a sensitive business. But tests can be expensive. If they go wrong, companies are liable for compensation. No surprise, then, that in...
Read More »








